BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. The company has strategic collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, and Bristol Myers Squibb company. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of BeiGene Ltd. American Depositary Shares.
BeiGene Ltd. American Depositary Shares business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of BeiGene Ltd. American Depositary Shares are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of BeiGene Ltd. American Depositary Shares , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of BeiGene Ltd. American Depositary Shares including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of BeiGene Ltd. American Depositary Shares and all latest updates of the company are provided.
The 2025 version of BeiGene Ltd. American Depositary Shares report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 BeiGene Ltd. American Depositary Shares- Key Facts
2.2 BeiGene Ltd. American Depositary Shares- Geographic Locations
2.3 BeiGene Ltd. American Depositary Shares- Subsidiaries and Affiliates
2.4 BeiGene Ltd. American Depositary Shares- Business Divisions
2.5 BeiGene Ltd. American Depositary Shares- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. BeiGene Ltd. American Depositary Shares Strategic Analysis Review
3.1 BeiGene Ltd. American Depositary Shares- Key Strategies
3.2 BeiGene Ltd. American Depositary Shares- Company Outlook Statement
3.3 BeiGene Ltd. American Depositary Shares- SWOT Analysis
3.3.1 BeiGene Ltd. American Depositary Shares- Key Strengths
3.3.2 BeiGene Ltd. American Depositary Shares- Key Weaknesses
3.3.3 BeiGene Ltd. American Depositary Shares- Potential Opportunities
3.3.4 BeiGene Ltd. American Depositary Shares- Potential Threats
3.4 BeiGene Ltd. American Depositary Shares- Key Competitors
4. Business Description of the Company
4.1 BeiGene Ltd. American Depositary Shares- Business Overview
4.2 BeiGene Ltd. American Depositary Shares- Operations by Segment
5 Products and Services Details
5.1 BeiGene Ltd. American Depositary Shares- Key Products
5.2 BeiGene Ltd. American Depositary Shares- Key Service Areas
5.3 BeiGene Ltd. American Depositary Shares- Key Brands
6 Company Developments
6.1 BeiGene Ltd. American Depositary Shares- Company History
6.2 BeiGene Ltd. American Depositary Shares- Latest Developments
7 Financial Analysis
7.1 BeiGene Ltd. American Depositary Shares- Income Statements
7.2 BeiGene Ltd. American Depositary Shares- Balance Sheet
7.3 BeiGene Ltd. American Depositary Shares- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 BeiGene Ltd. American Depositary Shares- Direct Competitors
8.2 BeiGene Ltd. American Depositary Shares- Competitor Financial Ratios comparison
8.3 BeiGene Ltd. American Depositary Shares- Competitor Stock Charts Comparison
8.4 BeiGene Ltd. American Depositary Shares- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!